BioLineRx recognizes the vast potential of early stage chemical and biological research, but realizes that it is only with the careful design and implementation of a sound development plan will this potential be realized.

BioLineRx builds its pipeline by in-licensing promising compounds from scientists, universities and biotech companies and advances these projects through the clinical testing stage. BioLineRx's experienced management team, SAB and Board of Directors, apply a complex and rigorous screening process in order to determine which projects will be accepted. Once a project is accepted BioLineRx designs a comprehensive drug development plan and assumes full responsibility for its progress and success. Throughout the process, BioLineRx strives to maintain strong involvement of the inventors, companies and universities as partners in the drug development program.

BioLineRx is continuously seeking new therapeutic projects for a wide array of indications including Autoimmune, Central Nervous System, Cancer, Cardiovascular and Metabolic Disorders. We welcome submissions meeting our evaluation criteria.